Journal
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Volume 175, Issue -, Pages 1-6Publisher
ELSEVIER
DOI: 10.1016/j.ejpb.2022.04.007
Keywords
Edelfosine; Lipid nanoparticles; Biodistribution; Technetium-99m
Categories
Funding
- Caja Navarra Foundation, University of Navarra (FUN)
- Government of Navarra, Department of Health [63/09]
- Spanish Ministry of Science and Innovation [SAF2010-15547]
- Asociacion de Amigos de la Universidad de Navarra
- COST Action [TD1004]
Ask authors/readers for more resources
Nanoencapsulated Edelfosine is effective in various types of tumors, and biodistribution studies revealed that the intraperitoneal route is optimal for sustaining consistent blood levels and avoiding accumulation in RES organs.
Edelfosine (ET) is a potent antitumor agent but causes severe side effects that have limited its use in clinical practice. For this reason, nanoencapsulation in lipid nanoparticles (LNs) is advantageous as it protects from ET side-effects. Interestingly, previous studies showed the efficacy of LNs containing ET in various types of tumor. In this paper, biodistribution studies of nanoencapsulated ET, administered by three routes (oral, intravenous (IV) and intraperitoneal (IP)), were tested in order to select the optimal route of administration. To do this, ET-LNs were labeled with Technetium-99 m (Tc-99m) and administered by the oral, IV and IP route in mice. IV administration of the radiolabeled LNs led to fast elimination from the blood circulation and increased accumulation in reticulo-endothelial (RES) organs, while their oral administration could not provide any evidence on their biodistribution since large radiocomplexes were formed in the presence of gastrointestinal fluids. However, when the LNs were administered by the IP route they could access the systemic circulation and provided more constant blood ET-LN levels compared to the IV route. These findings suggest that the IP route can be used to sustain the level of drug in the blood and avoid accumulation in RES organs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available